Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences -- Ignore unavailable to you. Want to Upgrade?

To: mokelumne river who wrote (1885)	4/26/2016 5:20:02 PM
From: Strong Long	Respond to of 2026

James, I always value your opinion and in this case it's no different. Thanks for your thoughts, you have very vaild points. I could not agree more that the market is very US centric, and that is a very significant point moving forward...US approval is probably more important than any other event. I hope that the Executives that remain are skilled towards that end, to pull it off. MI and your discussion about that subject on this board was very valuable, and I agree that Apricus does have the people in place to be successful. Provided US approval of Vitaros happens, my only concern at that point becomes successful US marketing. Canada still leaves a bad taste in the mouth, and no one knows what happened with that. Still, in line with the points you make, that may be a moot point if US investors run with it... Hoping for good times ahead :)